Vestcor Inc’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$162K Hold
1,480
﹤0.01% 1066
2025
Q4
$120K Hold
1,480
﹤0.01% 1037
2025
Q3
$130K Hold
1,480
﹤0.01% 1051
2025
Q2
$123K Sell
1,480
-1,599
-52% -$134K ﹤0.01% 1043
2025
Q1
$258K Buy
3,079
+1,599
+108% +$149K 0.01% 896
2024
Q4
$136K Hold
1,480
﹤0.01% 1053
2024
Q3
$137K Hold
1,480
﹤0.01% 1018
2024
Q2
$122K Hold
1,480
﹤0.01% 1037
2024
Q1
$98K Sell
1,480
-987
-40% -$60.9K ﹤0.01% 1100
2023
Q4
$140K Hold
2,467
﹤0.01% 1051
2023
Q3
$134K Hold
2,467
﹤0.01% 1078
2023
Q2
$166K Hold
2,467
0.01% 877
2023
Q1
$127K Hold
2,467
﹤0.01% 987
2022
Q4
$114K Buy
+2,467
New +$116K ﹤0.01% 1045

Other funds holding LMAT

Vestcor Inc's LMAT Position: Q1 2026 in Review

Vestcor Inc held its LeMaitre Vascular (LMAT) position steady in Q1 2026 at 1,480 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #1066.

Vestcor Inc first reported a position in LMAT in Q4 2022 and has held it in 14 quarters since. The position peaked at $258K in Q1 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Vestcor Inc held 1,480 shares of LeMaitre Vascular worth $162K as of Q1 2026.
  • Vestcor Inc left its LeMaitre Vascular share count unchanged in Q1 2026.
  • LeMaitre Vascular made up ﹤0.01% of Vestcor Inc's portfolio in Q1 2026, its #1066 holding.
  • Vestcor Inc first reported a position in LeMaitre Vascular in Q4 2022 and has held it in 14 quarters since.
  • Vestcor Inc's LeMaitre Vascular position peaked at $258K in Q1 2025.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.